One of the leading causes of disability in the U.S. is major depressive disorder (MDD), affecting more than 16.1 million adults each year. Another perhaps more shocking statistic is that about 80% of those people never seek treatment, for various reasons. However, one...
Last year, on June 23, twelve young boys—members of the Wild Boars youth soccer team—and their coach were unexpectedly trapped inside an underground cave system in Thailand. When flood water quickly and unexpectedly rose, their exploration went from fun and exciting...
An expectant mother is about to experience extreme lifestyle changes, on top of the immediate emotional and physical stress of childbirth. Dealing with these newfound challenges—sleep deprivation, the responsibility of nurturing a newborn, and the underlying stress of...
The recent FDA approval of the use of esketamine for treatment-resistant depression means many Americans suffering will soon find relief. The drug, Spravato, was approved for patients who have failed to respond at all to at least two other antidepressant medications....
Depression is a mental disorder that affects 350 million people world wide. According to a medical paper published by Louisiana State University Health Sciences Center, people in the United States 18 years and older make up 4.6% of those 350 million. The study, which...
Since it was developed in 2016, we’ve blogged several times about esketamine—the isomer of ketamine being developed by Janssen Pharmaceuticals, designed to rapidly alleviate the symptoms of treatment-resistant depression. Esketamine, which will be administered...
